SI2487161T1 - Modulatorji farmakokinetičnih lastnosti terapevtikov - Google Patents

Modulatorji farmakokinetičnih lastnosti terapevtikov

Info

Publication number: SI2487161T1
Authority: SI; Slovenia
Prior art keywords: therapeutics; modulators; pharmacokinetic properties; pharmacokinetic; properties
Prior art date: 2007-02-23

Application number

SI200831700T

Other languages

English (en)

Other versions

SI2487161T2 (sl

Inventor

Manoj C. Desai

Allen Y. Hong

Hon C. Hui

Hongtao Liu

Radall W. Vivian

Lianhong Xu

Original Assignee

Gilead Sciences, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-23

Filing date

2008-02-22

Publication date

2016-12-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46465350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2487161(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-22 Application filed by Gilead Sciences, Inc. filed Critical Gilead Sciences, Inc.

2008-02-22 Priority claimed from EP12167589.6A external-priority patent/EP2487161B2/en

2016-12-30 Publication of SI2487161T1 publication Critical patent/SI2487161T1/sl

2024-07-31 Publication of SI2487161T2 publication Critical patent/SI2487161T2/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SI200831700T 2007-02-23 2008-02-22 Modulatorji farmakokinetičnih lastnosti terapevtikov SI2487161T2 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US90322807P	2007-02-23	2007-02-23
US95871607P	2007-07-06	2007-07-06
EP12167589.6A EP2487161B2 (en)	2007-02-23	2008-02-22	Modulators of pharmacokinetic properties of therapeutics

Publications (2)

Publication Number	Publication Date
SI2487161T1 true SI2487161T1 (sl)	2016-12-30
SI2487161T2 SI2487161T2 (sl)	2024-07-31

Family

ID=46465350

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
SI200831705A SI2487162T1 (sl)	2007-02-23	2008-02-22	Modulatorji farmakokinetičnih lastnosti terapevtskih sredstev
SI200831693A SI2487163T1 (sl)	2007-02-23	2008-02-22	Modulatorji farmakokinetičnih lastnosti terapevtskih sredstev
SI200831700T SI2487161T2 (sl)	2007-02-23	2008-02-22	Modulatorji farmakokinetičnih lastnosti terapevtikov
SI200831691A SI2487166T1 (sl)	2007-02-23	2008-02-22	Modulatorji farmakokinetičnih lastnosti terapevtskih sredstev

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
SI200831705A SI2487162T1 (sl)	2007-02-23	2008-02-22	Modulatorji farmakokinetičnih lastnosti terapevtskih sredstev
SI200831693A SI2487163T1 (sl)	2007-02-23	2008-02-22	Modulatorji farmakokinetičnih lastnosti terapevtskih sredstev

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI200831691A SI2487166T1 (sl)	2007-02-23	2008-02-22	Modulatorji farmakokinetičnih lastnosti terapevtskih sredstev

Country Status (8)

Country	Link
EP (6)	EP2487168A1 (sl)
DK (3)	DK2487163T3 (sl)
HU (2)	HUS1600053I1 (sl)
ME (4)	ME02628B (sl)
PL (2)	PL2487163T3 (sl)
RS (4)	RS55351B2 (sl)
SI (4)	SI2487162T1 (sl)
UA (1)	UA101312C2 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2802315A1 (en) *	2012-01-12	2014-11-19	Gilead Sciences, Inc.	Pharmaceutical compositions and methods for their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6037157A (en) *	1995-06-29	2000-03-14	Abbott Laboratories	Method for improving pharmacokinetics
CN101361723B (zh)	1999-06-04	2013-11-06	Abbvie公司	改进的药物制剂
HUE025565T4 (en)	2006-07-07	2017-01-30	Gilead Sciences Inc	Modulators of pharmacokinetic properties of therapeutics
AU2008218186C1 (en)	2007-02-23	2014-07-17	Gilead Sciences, Inc.	Modulators of pharmacokinetic properties of therapeutics

2008
- 2008-02-22 SI SI200831705A patent/SI2487162T1/sl unknown
- 2008-02-22 ME MEP-2016-260A patent/ME02628B/me unknown
- 2008-02-22 EP EP20120167599 patent/EP2487168A1/en not_active Withdrawn
- 2008-02-22 RS RS20160857A patent/RS55351B2/sr unknown
- 2008-02-22 ME MEP-2016-263A patent/ME02631B/me unknown
- 2008-02-22 RS RS20160992A patent/RS55459B1/sr unknown
- 2008-02-22 EP EP12167590.4A patent/EP2487162B1/en not_active Revoked
- 2008-02-22 PL PL12167591T patent/PL2487163T3/pl unknown
- 2008-02-22 UA UAA200909677A patent/UA101312C2/ru unknown
- 2008-02-22 SI SI200831693A patent/SI2487163T1/sl unknown
- 2008-02-22 EP EP12167591.2A patent/EP2487163B1/en not_active Revoked
- 2008-02-22 PL PL12167596T patent/PL2487166T3/pl unknown
- 2008-02-22 ME MEP-2016-262A patent/ME02680B/me unknown
- 2008-02-22 DK DK12167591.2T patent/DK2487163T3/en active
- 2008-02-22 RS RS20160883A patent/RS55280B1/sr unknown
- 2008-02-22 DK DK12167589.6T patent/DK2487161T4/da active
- 2008-02-22 SI SI200831700T patent/SI2487161T2/sl unknown
- 2008-02-22 RS RS20160889A patent/RS55195B1/sr unknown
- 2008-02-22 DK DK12167590.4T patent/DK2487162T3/en active
- 2008-02-22 EP EP20120167597 patent/EP2487167A1/en not_active Withdrawn
- 2008-02-22 EP EP20120167593 patent/EP2487164A1/en not_active Withdrawn
- 2008-02-22 SI SI200831691A patent/SI2487166T1/sl unknown
- 2008-02-22 EP EP12167596.1A patent/EP2487166B1/en not_active Revoked
- 2008-02-22 ME MEP-2016-241A patent/ME02582B/me unknown
2016
- 2016-12-12 HU HUS1600053C patent/HUS1600053I1/hu unknown
- 2016-12-12 HU HUS1600052C patent/HUS1600052I1/hu unknown

Also Published As

Publication number	Publication date
RS55459B1 (sr)	2017-04-28
EP2487168A1 (en)	2012-08-15
DK2487162T3 (en)	2016-10-24
HUS1600052I1 (hu)	2017-01-30
UA101312C2 (ru)	2013-03-25
SI2487162T1 (sl)	2016-12-30
EP2487162B1 (en)	2016-08-17
DK2487161T3 (en)	2016-10-24
EP2487162A1 (en)	2012-08-15
ME02582B (me)	2017-06-20
EP2487163B1 (en)	2016-08-17
PL2487166T3 (pl)	2017-07-31
RS55351B1 (sr)	2017-03-31
ME02680B (me)	2017-06-20
DK2487163T3 (en)	2016-10-24
PL2487163T3 (pl)	2017-04-28
ME02628B (me)	2017-06-20
EP2487164A1 (en)	2012-08-15
RS55351B2 (sr)	2024-09-30
SI2487161T2 (sl)	2024-07-31
SI2487166T1 (sl)	2017-02-28
EP2487166B1 (en)	2016-07-27
EP2487163A1 (en)	2012-08-15
RS55195B1 (sr)	2017-01-31
RS55280B1 (sr)	2017-03-31
ME02631B (me)	2017-06-20
HUS1600053I1 (hu)	2017-01-30
EP2487167A1 (en)	2012-08-15
DK2487161T4 (da)	2024-06-24
EP2487166A1 (en)	2012-08-15
SI2487163T1 (sl)	2016-12-30

Publication	Publication Date	Title
HUS2000013I1 (hu)	2020-06-29	Gyógyszerek farmakokinetikai tulajdonságainak modulátorai
AP2985A (en)	2014-09-30	Modulators of pharmacokinetic properties of therapeutics
HK1143144A1 (en)	2010-12-24	Modulators of pharmacokinetic properties of therapeutics
HUS1600053I1 (hu)	2017-01-30	Terápiás szerek farmakokinetikai paramétereinek modulálása